Clinical Partnerships Set the Stage for Surgical AI Adoption

A Genesis MedTech and NUHS partnership shows how closer clinician collaboration could shape the next chapter of surgical AI

10 Feb 2026

Artificial intelligence has long promised to reshape surgery, but progress has been slower and more uneven than early advocates predicted. After years of striking demonstrations and limited real-world use, the field is moving into a more pragmatic phase, where collaboration with clinicians is becoming as important as technical skill.

A partnership between Genesis MedTech and Singapore’s National University Health System (NUHS), announced in late 2025 and now under way, reflects that change in approach. Rather than pursuing highly automated visions of surgery, the collaboration is focused on the practical demands of the operating theatre.

The stated aim is to develop AI tools that surgeons are willing and able to use. Engineers are working closely with clinicians to observe existing workflows, collect structured feedback and provide hands-on training. The emphasis is on decision support that fits quietly into established routines, rather than systems that disrupt them. Industry analysts see this as an acknowledgement that usability and trust must be designed from the outset.

For Genesis MedTech, the partnership supports its broader strategy to expand into digital and data-driven healthcare. Access to a large public health system gives the company detailed insight into how surgical teams work in practice, where delays arise and where technology may add value. The group has said it wants AI to operate largely in the background, reinforcing familiar processes instead of replacing them.

NUHS, for its part, gains influence over how surgical AI develops. Like many health systems, it faces pressure to improve patient safety, manage costs and train new surgeons. While AI offers potential gains in consistency and efficiency, it also raises questions about responsibility and appropriate use. Early involvement allows clinicians to shape standards and prepare staff for new tools.

A central element of the partnership is a dedicated AI innovation and surgical training laboratory, where technologies can be tested and refined before being used on patients. Supporters say this addresses a common weakness in surgical AI, where systems perform well in controlled settings but struggle in routine practice.

Significant obstacles remain, including data governance, regulation and the challenge of scaling beyond a single institution. There is no clear evidence yet that the partnership will speed adoption. Even so, it is seen as a signal that progress in surgical AI may depend less on bold claims, and more on learning from those in the operating room.